Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.1 | uM | 7 | 625.00 | 270.29 | 264.00 | 821.75 | 0.3213 | -0.0146 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 886.00 | 821.75 | 1.0782 | 1.0961 |
| BT-20 | Erlotinib | 1 | uM | 7 | 625.00 | 270.29 | 665.00 | 821.75 | 0.8093 | 0.7528 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 1040.00 | 821.75 | 1.2656 | 1.3163 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 739.00 | 821.75 | 0.8993 | 0.8720 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 625.00 | 270.29 | 255.00 | 821.75 | 0.3103 | -0.0357 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 625.00 | 270.29 | 981.00 | 821.75 | 1.1938 | 1.2335 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 1028.00 | 821.75 | 1.2510 | 1.2996 | |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 625.00 | 270.29 | 887.00 | 821.75 | 1.0794 | 1.0976 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 625.00 | 270.29 | 808.00 | 821.75 | 0.9833 | 0.9791 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 817.00 | 821.75 | 0.9942 | 0.9928 |
| BT-20 | Linsitinib | 1 | uM | 7 | 625.00 | 270.29 | 898.00 | 821.75 | 1.0928 | 1.1137 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 625.00 | 270.29 | 685.00 | 821.75 | 0.8336 | 0.7855 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 785.00 | 821.75 | 0.9553 | 0.9438 |
| BT-20 | 17-AAG | 1 | uM | 7 | 625.00 | 270.29 | 277.00 | 821.75 | 0.3371 | 0.0154 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 819.00 | 821.75 | 0.9967 | 0.9958 | |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 625.00 | 270.29 | 797.00 | 821.75 | 0.9699 | 0.9622 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 740.00 | 821.75 | 0.9005 | 0.8735 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 790.00 | 821.75 | 0.9614 | 0.9515 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 6.00 | 821.75 | 0.0073 | -0.9069 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2.00 | 1907.25 | 0.0010 | -0.9632 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1779.00 | 1907.25 | 0.9328 | 0.9205 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 1250.00 | 580.08 | 625.00 | 1907.25 | 0.3277 | 0.0444 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1676.00 | 1907.25 | 0.8788 | 0.8550 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1628.00 | 1907.25 | 0.8536 | 0.8239 |